Breast cancer drug may throw patients off balance
NCT ID NCT06184074
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 28 times
Summary
This study measured balance and fall risk in 76 postmenopausal women with stage 1-3 breast cancer who had finished chemotherapy. Half were taking aromatase inhibitors for at least a year, and half had never taken them. Researchers used special balance tests and ultrasound to see if the drug affects stability.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ece Küçük
Istanbul, 34457, Turkey (Türkiye)
Conditions
Explore the condition pages connected to this study.